Witold Kozlowski retweeted
📌 Integration of ultrasound-guided motion management into proton therapy treatment plans for ventricular tachycardia 🫀 non-invasive radio ablation
🔗 pubmed.ncbi.nlm.nih.gov/4088…
@OncoAlert #OncoAlertAF #STAR
#CardiacRadioablation #ProtonTherapy
👉🏻 We studied the integration of a novel ultrasound probe and holder for heart motion management into proton‐beam STAR treatment plans.
It would facilitate dedicated patient setup, monitoring and cardiorespiratory gating for STAR using proton beams.
Stefania Colasanti retweeted
Kudos to2⃣ Amazing @OncoAlert 🚨Colleagues !
Proud of @MarioBalsaMD & @DrMirallas 🇪🇸
WE ARE #OncoAlertAF🌐
And finally a huge thank you to @DrMirallas for being such an incredible mentor and support. An oncologist driven by curiosity, motivation, and a true passion for teaching 💥
Grateful to have met you at @MDAndersonNews! 🙏
#Oncology #Mentorship #MedicalTraining
Cancer Links retweeted
📌 Ten-Year Survival after Postmastectomy Chest-Wall Irradiation in Breast Cancer
🔸The SUPREMO trial 10-yr data is out.
🔗 nejm.org/doi/full/10.10…
@OncoAlert #OncoAlertAF #RadOnc @NEJM
IJROBP - The Red Journal retweeted
📌 Post-Operative Single Fraction Stereotactic Partial Breast Irradiation (S-PBI) for Early-Stage Breast Cancer with Gammapod™ Technology: A Phase II Clinical Trial
🔗redjournal.org/article/S0360…
@OncoAlert #OncoAlertAF @PriscoA78
👉🏻Single-fraction S-PBI using GammaPod™ was associated with excellent tolerability and promising early oncologic control in early breast cancer. With minimal late toxicity this approach offers an efficient, patient-friendly alternative to multi-fraction regimens.
Manju George MVSc PhD Rectal Cancer Survivor retweeted
My #OncoAlertAF “TOP3” from #ESMO25… featuring a bold new format: just two.
✅ NICHE-2
✅ STELLAR-303
Because quality > quantity 😎
@OncoAlert
@TheGutOncLab
@UGrewalMD
@TimothyJBrownMD
Our #OncoAlertAF 🚨Colleague @GIMedOnc 🇺🇸 of @NorthwellHealth with his TOP picks of #GIOncology Trials Presented at #ESMO25 🇩🇪for the OncoAlert TOP3 Series post ESMO 2025, more to come..
✅NICHE2
✅STELLAR 303
@pashtoonkasi @CathyEngMD @marklewismd @AndresC27622123 @manjuggm @stacy_hurt @ARosen380 @KoheiShitara @GillSharlene @BenWestphalen @NiuSanford
#OncoAlertAF
@nataliagandur @acampsmalea @BRicciutiMD
@HHorinouchi @FadiHaddad_MD
@Abdallah81MD @FernandoOnco
@ElisaAgostinett @to_be_elizabeth @bavilima @realbowtiedoc @Erman_Akkus @Lucarecco @GaiaGriguolo @JankovicK
@MarioBalsaMD @DrMirallas @GIMedOnc @OscarTahuahua @UOzkerim @DrRishabhOnco @Onco_Cifu88 @matteolambe @Icro_Meattini @COR2EDMedEd @VJOncology
Chris retweeted
💥New @JAMAOnc consensus: NGS should be used selectively in sarcoma—guided by subtype, context, and expert review!
jamanetwork.com/journals/jam…
Routine panels? Not yet ready for prime time
Precision needs precision 🎯
@OncoAlert #OncoAlertAF @OncoReporte @myESMO @_SEOM @SarcomaSmart